Arena Pharmaceuticals Inc
ARNADelisted Mar 11, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001080709
Arena Pharmaceuticals Inc was delisted on Mar 11, 2022; its insiders filed their last Form 4 on Mar 11, 2022; 317 institutions reported holding it in 13F filings for Q4 2021, worth $4.87B in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Arena Pharmaceuticals Inc changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Of which not filed for Q2 2021 | Q2 2021 | Change |
|---|---|---|---|---|
| Holders | 234 | 1 | 236 | +3 |
| Shares | 56.1M | 4.80K | 56.8M | +703.0K (+1.3%) |
| Value | $3.89B | $333.0K | $3.87B | −$19.2M (−0.5%) |
1 institution that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (38)
Institutions that held Arena Pharmaceuticals Inc at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (35)
Institutions that held Arena Pharmaceuticals Inc at the end of Q1 2021 and filed for Q2 2021 without it.
Not filed for Q2 2021 yet (1)
Institutions that held Arena Pharmaceuticals Inc at the end of Q1 2021 and haven't filed a 13F for Q2 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Amundi Asset Management US, Inc. | 4,800 | $333.0K |